SELLAS Life Sciences (SLS) Return on Capital Employed Growth (5y) (2017 - 2026)
SELLAS Life Sciences (SLS) Return on Capital Employed Growth (5y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
767,934.24 Bn |
767,934.20 Bn |
- |
| 2 |
Belite Bio |
55,234.00 Bn |
55,234.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,823.14 Bn |
17,823.14 Bn |
- |
| 4 |
Legend Biotech |
3,624.50 Bn |
3,624.21 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,745.73 Bn |
1,745.73 Bn |
- |
| 6 |
Evaxion A |
1,540.85 Bn |
1,540.84 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.57 Bn |
105.33 Bn |
2.59 Bn |
| 9 |
Abivax |
93.46 Bn |
93.46 Bn |
- |
| 10 |
SELLAS Life Sciences |
1.34 Bn |
1.34 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
557.00 |
| Dec 31, 2025 |
3,635.00 |
| Sep 30, 2025 |
9,928.00 |
| Jun 30, 2025 |
8,835.00 |
| Mar 31, 2025 |
2,945.00 |
| Dec 31, 2022 |
-39,162.00 |
| Sep 30, 2022 |
-24,543.00 |
| Jun 30, 2022 |
-27,531.00 |
| Mar 31, 2022 |
27,270.00 |
| Dec 31, 2021 |
-4,603.00 |
| Sep 30, 2021 |
5,475.00 |
| Jun 30, 2021 |
11,039.00 |
| Mar 31, 2021 |
6,639.00 |
| Dec 31, 2020 |
4,991.00 |
| Sep 30, 2020 |
-10,833.00 |
| Jun 30, 2020 |
-12,978.00 |
| Mar 31, 2020 |
-9,280.00 |
| Dec 31, 2017 |
-1,760.00 |
